Danaher (DHR) P/E (2009 - 2026)
Danaher (DHR) P/E from Jul 6, 2009 to Jul 21, 2026. The TTM Danaher (DHR) P/E is 34.40. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Danaher (DHR)
| Year | P/E | Change |
|---|---|---|
| 2026 | 34.40 | -23.56% |
| 2025 | 45.00 | +5.16% |
| 2024 | 42.79 | +49.44% |
| 2023 | 28.63 | +1.18% |
| 2022 | 28.30 | -22.51% |
| 2021 | 36.52 | -15.34% |
| 2020 | 43.14 | +19.43% |
| 2019 | 36.12 | +32.61% |
| 2018 | 27.24 | +0.74% |
| 2017 | 27.04 | +25.78% |
| 2016 | 21.49 | +11.93% |
| 2015 | 19.20 | -78.69% |
| 2014 | 90.12 | +312.33% |
| 2013 | 21.86 | +29.03% |
| 2012 | 16.94 | +21.37% |
| 2011 | 13.96 | -23.97% |
| 2010 | 18.36 | -87.19% |
| 2009 | 143.29 | N/A |
Comparison Danaher (DHR) P/E with competitors
Danaher (DHR) P/E is 34.40.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -96.95% |
| MBAI | CheckCap Ltd | 1.71 | -95.02% |
| FONR | Fonar Corp | 15.48 | -55.00% |
| QGEN | Qiagen NV | 20.03 | -41.77% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -30.60% |
| IQV | IQVIA Holdings Inc | 25.28 | -26.50% |
| A | Agilent Technologies Inc | 26.96 | -21.63% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -8.34% |
| MTD | Mettler-Toledo International Inc | 32.45 | -5.66% |
| MEDP | Medpace Holdings Inc | 32.55 | -5.37% |
| IDXX | Idexx Laboratories Inc | 40.58 | +17.96% |
| ILMN | Illumina Inc | 44.12 | +28.27% |
| RVTY | Revvity Inc | 52.68 | +53.16% |
| VCYT | Veracyte Inc | 53.71 | +56.16% |
| ICLR | Icon Plc | 57.45 | +67.03% |
| SHC | Sotera Health Company | 74.08 | +115.38% |
| WAT | Waters Corp | 102.79 | +198.83% |